EORTC-24863-HNCG

Phase II Randomized Chemotherapy Trial of CHIP vs CACP in Patients with Advanced Ovarian Cancer Refractory or Recurrent After First-Line Chemotherapy with CBDCA (Summary Last Modified 05/88
Trial StatusAll trial activities ended
DatesDate of activation: 15-Oct-86
Closed on : 15-Nov-87
Data management at EORTCFull
Phase2
Randomized trial
Type-
Targeted Sample size14
Number of steps1
Drug
Study Staff
Type of cancerHead and Neck
Participating GroupsEORTC Head and Neck Cancer Group(Coordinating Group)
Protocol summaryClinicalTrials.gov
NCT number
EudraCT